Liquidia (LQDA) Research & Development (2020 - 2026)
Liquidia (LQDA) recorded quarterly Research & Development of $12.6 million in Q1 2026, down 25.8% quarter-over-quarter from $16.9 million in Q4 2025, and up 80.46% on a YoY basis from $7.0 million in Q1 2025.
Liquidia (LQDA) Research & Development (2020 - 2026) Analysis & Trends
Liquidia's Research & Development history runs 7 years deep, the most recent figure standing at $12.6 million for Q1 2026.
- In Q1 2026, Research & Development rose 80.46% year-over-year to $12.6 million; the TTM figure through Mar 2026 stood at $44.9 million (changed 0.29% YoY), while the FY2025 annual figure was $39.3 million, down 17.9% from the prior year.
- Research & Development was $12.6 million for Q1 2026 at Liquidia, down from $16.9 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $17.7 million in Q2 2023 to a low of $4.5 million in Q3 2022.
- Historically, Research & Development has averaged $9.6 million across 5 years, with a median of $9.3 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Research & Development soared 239.05% in 2023, then sank 46.76% in 2024.
- A 5-year view of Research & Development shows it stood at $5.0 million in 2022, then soared by 157.82% to $12.8 million in 2023, then gained by 28.42% to $16.5 million in 2024, then gained by 2.84% to $16.9 million in 2025, then retreated by 25.8% to $12.6 million in 2026.
- The last three Research & Development figures came in at $12.6 million (Q1 2026), $16.9 million (Q4 2025), and $9.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 46.94 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 39.38 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 12.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.57 Mn |
| Dec 31, 2025 | 16.94 Mn |
| Sep 30, 2025 | 9.35 Mn |
| Jun 30, 2025 | 6.02 Mn |
| Mar 31, 2025 | 6.97 Mn |
| Dec 31, 2024 | 16.48 Mn |
| Sep 30, 2024 | 11.89 Mn |
| Jun 30, 2024 | 9.42 Mn |
| Mar 31, 2024 | 10.06 Mn |
| Dec 31, 2023 | 12.83 Mn |
| Sep 30, 2023 | 7.44 Mn |
| Jun 30, 2023 | 17.70 Mn |
| Mar 31, 2023 | 5.28 Mn |
| Dec 31, 2022 | 4.98 Mn |
| Sep 30, 2022 | 4.51 Mn |
| Jun 30, 2022 | 5.22 Mn |
| Mar 31, 2022 | 4.73 Mn |
| Dec 31, 2021 | 5.38 Mn |
| Sep 30, 2021 | 4.49 Mn |
| Jun 30, 2021 | 4.60 Mn |